Medicus Pharma submits European filing for Teverelix prostate cancer study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. QQQ
8. UNFI
9. SPY
10. ASO

Go back to Medicus Pharma submits European filing for Teverelix prostate cancer study
(NASDAQ: MDCX) Delayed: 0.16 -0.01 (5.88%)
Previous Close $0.17    52 Week High $ 
Open $0.16    52 Week Low $ 
Day High $0.16    P/E N/A 
Day Low $0.16    EPS $ 
Volume 772,156